Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joshua Hickman

Orthopaedic Surgery Bountiful, UT Medical Doctor

NPI 1821139619 CMS profile 37713

1551 Renaissance Towne Dr, Ste. 400, Bountiful, UT 84010

Open in the dashboard

General payments

$2,709,319

479 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joshua Hickman of Bountiful, UT is reported in the CMS Open Payments database as having received $2,709,319 across 479 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $458,523 63
2024 General $420,580 48
2023 General $406,779 61
2022 General $427,528 84
2021 General $320,163 49
2020 General $272,328 52
2019 General $403,419 122

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joshua Hickman
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Joshua Hickman were reported at $458,523. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Joshua Hickman Orthopaedic Surgery median Middle half National median
2019 $403,419 $644 $140–$2,844 $163
2020 $272,328 $312 $75–$1,860 $114
2021 $320,163 $520 $117–$2,495 $132
2022 $427,528 $598 $128–$2,731 $149
2023 $406,779 $461 $128–$2,264 $160
2024 $420,580 $497 $134–$2,475 $164
2025 $458,523 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Ortho Development Corporation $2,665,014 381 payments
  2. Stryker Corporation $26,010 80 payments
  3. Orthalign Inc $9,885 4 payments
  4. Think Surgical, Inc. $8,245 7 payments
  5. Pacira Pharmaceuticals Incorporated $37 1 payment
  6. Smith+Nephew, Inc. $31 1 payment
  7. Ethicon US, LLC $30 1 payment
  8. Innovation Technologies Inc $20 1 payment
  9. DePuy Synthes Sales Inc. $20 1 payment
  10. Pfizer Inc. $15 1 payment
  11. Other $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $2,156,612 230 payments
  2. Consulting Fee $513,610 148 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $15,000 1 payment
  4. Travel and Lodging $13,562 54 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $8,000 1 payment
  6. Food and Beverage $2,535 45 payments
Products named General payments · program years 2019–2025
  1. Legend orthopedic device $1,041,073 63 payments
  2. Alpine Hip System $619,621 74 payments
  3. Balance Knee Revision System $594,347 75 payments
  4. Trivicta $320,288 31 payments
  5. Legend orthopedic device $261,313 25 payments
  6. Balanced Knee Revision System $231,474 25 payments
  7. BKS Revision $230,539 33 payments
  8. Alpine $105,470 30 payments
  9. BKS Revision II $68,500 8 payments
  10. BKS Uni $53,000 16 payments
  11. Other $73,609 112 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

49

Median for Orthopedic Surgery: 203

Drug cost

$76

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin Generic 49 $76

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 41 billing codes

Paid by Medicare

$298,431

Of which drugs: $346

Medicare patients

560

Average age 74

Services billed

2,505

328 women, 232 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Depression 29%
Diabetes 26%
Chronic kidney disease 24%
Ischemic heart disease 17%
Osteoporosis 15%
Cancer 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 41 461 $325

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

479 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record